US Patent 7928073 Purified polypeptides having IL-13 receptor activity
Patent 7928073 was granted and assigned to Sanofi on April, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7928073 Purified polypeptides having IL-13 receptor activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
